AstraZeneca Reports Third-Quarter Core Earnings of $2.79 Per Share
Photo: TokenPost
Core earnings per share rose 19% at constant exchange rates. Oncology revenue increased 16% in the first nine months of 2026.
Source: TokenPost
An independent desk covering Stake, the US casino market and crypto.
Photo: TokenPost
Core earnings per share rose 19% at constant exchange rates. Oncology revenue increased 16% in the first nine months of 2026.
Source: TokenPost
